103 related articles for article (PubMed ID: 862206)
1. Glucagon and diabetes. II. Complete suppression of glucagon by insulin in human diabetes.
Warne GL; Alford FP; Chisholm DJ; Court J
Clin Endocrinol (Oxf); 1977 Apr; 6(4):277-84. PubMed ID: 862206
[TBL] [Abstract][Full Text] [Related]
2. Influence of continuous physiologic hyperinsulinemia on glucose kinetics and counterregulatory hormones in normal and diabetic humans.
Saccà L; Sherwin R; Hendler R; Felig P
J Clin Invest; 1979 May; 63(5):849-57. PubMed ID: 447832
[TBL] [Abstract][Full Text] [Related]
3. Effects of insulin on the response of immunoreactive glucagon to an intravenous glucose load in human diabetes.
Yamamoto T; Raskin P; Aydin I; Unger R
Metabolism; 1979 May; 28(5):568-74. PubMed ID: 449698
[TBL] [Abstract][Full Text] [Related]
4. Suppressible glucagon secretion in young, ketosis-resistant, type "J" diabetic patients in India.
Rao RH; Vigg BL; Rao KS
Diabetes; 1983 Dec; 32(12):1168-71. PubMed ID: 6418596
[TBL] [Abstract][Full Text] [Related]
5. Studies of pancreatic alpha cell function in normal and diabetic subjects.
Unger RH; Aguilar-Parada E; Müller WA; Eisentraut AM
J Clin Invest; 1970 Apr; 49(4):837-48. PubMed ID: 4986215
[TBL] [Abstract][Full Text] [Related]
6. Effect of intranasal glucagon on blood glucose levels in healthy subjects and hypoglycaemic patients with insulin-dependent diabetes.
Freychet L; Rizkalla SW; Desplanque N; Basdevant A; Zirinis P; Tchobroutsky G; Slama G
Lancet; 1988 Jun; 1(8599):1364-6. PubMed ID: 2898045
[TBL] [Abstract][Full Text] [Related]
7. Effect of insulin-glucose infusions on plasma glucagon levels in fasting diabetics and nondiabetics.
Raskin P; Fujita Y; Unger RH
J Clin Invest; 1975 Nov; 56(5):1132-8. PubMed ID: 1184740
[TBL] [Abstract][Full Text] [Related]
8. Islet hormonal regulation of glucose turnover during exercise in type 1 diabetes.
Shilo S; Sotsky M; Shamoon H
J Clin Endocrinol Metab; 1990 Jan; 70(1):162-72. PubMed ID: 1967178
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the suppressive effects of elevated plasma glucose and free fatty acid levels on glucagon secretion in normal and insulin-dependent diabetic subjects. Evidence for selective alpha-cell insensitivity to glucose in diabetes mellitus.
Gerich JE; Langlois M; Noacco C; Lorenzi M; Karam JH; Korsham PH
J Clin Invest; 1976 Aug; 58(2):320-5. PubMed ID: 783198
[TBL] [Abstract][Full Text] [Related]
10. Impaired beta-cell function, incretin effect, and glucagon suppression in patients with type 1 diabetes who have normal fasting glucose.
Greenbaum CJ; Prigeon RL; D'Alessio DA
Diabetes; 2002 Apr; 51(4):951-7. PubMed ID: 11916912
[TBL] [Abstract][Full Text] [Related]
11. Effects of acute insulin withdrawal and administration on plasma glucagon responses to intravenous arginine in insulin-dependent diabetic subjects.
Gerich JE; Lorenzi M; Tsalikian E; Bohannon NV; Schneider V; Karam JH; Forsham PH
Diabetes; 1976 Oct; 25(10):955-60. PubMed ID: 976604
[TBL] [Abstract][Full Text] [Related]
12. Suppressibility of glucagon secretion by glucose in juvenile diabetes.
Sperling MA; Aleck K; Voina S
J Pediatr; 1977 Apr; 90(4):543-7. PubMed ID: 839365
[TBL] [Abstract][Full Text] [Related]
13. Glucagonostatic actions and reduction of fasting hyperglycemia by exogenous glucagon-like peptide I(7-36) amide in type I diabetic patients.
Creutzfeldt WO; Kleine N; Willms B; Orskov C; Holst JJ; Nauck MA
Diabetes Care; 1996 Jun; 19(6):580-6. PubMed ID: 8725855
[TBL] [Abstract][Full Text] [Related]
14. Role of hyperglucagonemia in maintenance of increased rates of hepatic glucose output in type II diabetics.
Baron AD; Schaeffer L; Shragg P; Kolterman OG
Diabetes; 1987 Mar; 36(3):274-83. PubMed ID: 2879757
[TBL] [Abstract][Full Text] [Related]
15. Important role of adrenergic mechanisms in acute glucose counterregulation following insulin-induced hypoglycemia in type I diabetes. Evidence for an effect mediated by beta-adrenoreceptors.
Bolli G; de Feo P; Compagnucci P; Cartechini MG; Angeletti G; Santeusanio F; Brunetti P
Diabetes; 1982 Jul; 31(7):641-7. PubMed ID: 6298039
[TBL] [Abstract][Full Text] [Related]
16. Adrenergic blockade alters glucose kinetics during exercise in insulin-dependent diabetics.
Simonson DC; Koivisto V; Sherwin RS; Ferrannini E; Hendler R; Juhlin-Dannfelt A; DeFronzo RA
J Clin Invest; 1984 Jun; 73(6):1648-58. PubMed ID: 6327767
[TBL] [Abstract][Full Text] [Related]
17. Hyperglycemia inhibits glucose production in man independent of changes in glucoregulatory hormones.
Sacca L; Hendler R; Sherwin RS
J Clin Endocrinol Metab; 1978 Nov; 47(5):1160-3. PubMed ID: 400737
[TBL] [Abstract][Full Text] [Related]
18. 24-hour studies of the effects of somatostatin on the levels of plasma growth hormone, glucagon, and glucose in normal subjects and juvenile diabetics.
Christensen SE; Hansen AP; Weeke J; Lundbaek K
Diabetes; 1978 Mar; 27(3):300-6. PubMed ID: 640235
[TBL] [Abstract][Full Text] [Related]
19. Hyperglucagonemia and blood glucose regulation in normal, obese and diabetic subjects.
Sherwin RS; Fisher M; Hendler R; Felig P
N Engl J Med; 1976 Feb; 294(9):455-61. PubMed ID: 1246330
[TBL] [Abstract][Full Text] [Related]
20. Loss of potentiating effect of hypoglycemia on the glucagon response to hyperaminoacidemia in IDDM.
Caprio S; Tamborlane WV; Zych K; Gerow K; Sherwin RS
Diabetes; 1993 Apr; 42(4):550-5. PubMed ID: 8454105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
